Gelteq Limited Ordinary Shares

Gelteq Limited Ordinary Shares

GELS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.92M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Gelteq Limited Ordinary SharesGelteq Limited Ordinary Shares-1.1--39%-0.4
$-0.27

Current Fair Value

197.1% downside

Overvalued by 197.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.92 Million
Enterprise Value$8.04 Million
Earnings per Share$0
Beta-0.36
Outstanding Shares10,394,733

Return

Return on Equity-39.45%ROE
Return on Assets-27.84%
Return on Invested Capital-35.83%

Valuation & Multiples

P/E Ratio-1.06P/E Ratio
PEG-1.63PEG
Price to Sales-Price to Sales
Price to Book Ratio0.28Price to Book Ratio
Enterprise Value to Revenue45.04
Enterprise Value to EBIT-1.57
Enterprise Value to Net Income-2
Total Debt to Enterprise0.64
Debt to Equity0.36Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Gelteq Limited Ordinary Shares

18 employees
CEO: Nathan Jacob Givoni

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formul...